相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
Athenais Grave et al.
FRONTIERS IN ONCOLOGY (2022)
A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
Gary M. Clifford et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Molecular characterization of squamous cell carcinoma of the anal canal
Samantha A. Armstrong et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Rao et al.
ANNALS OF ONCOLOGY (2021)
A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma
Soledad Iseas et al.
TRANSLATIONAL ONCOLOGY (2021)
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies
Feixue Wei et al.
LANCET HIV (2021)
Present and Future Research on Anal Squamous Cell Carcinoma
Laurie Spehner et al.
CANCERS (2021)
A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes
Camila Motta Venchiarutti Moniz et al.
JOURNAL OF CANCER (2021)
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma
Rebecca Shakir et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015
Ashish A. Deshmukh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection
Marcos Pedro Guedes Camandaroba et al.
CLINICAL COLORECTAL CANCER (2020)
Patterns of recurrence in anal cancer: a detailed analysis
Martin P. Nilsson et al.
RADIATION ONCOLOGY (2020)
Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients
Matthew Susko et al.
ONCOLOGIST (2020)
A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy
I Parwaiz et al.
CLINICAL ONCOLOGY (2019)
Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies
Carina Eklund et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy
Ali Hosni et al.
Oncotarget (2018)
Anal cancer in high-income countries: Increasing burden of disease
Yoon-Jung Kang et al.
PLOS ONE (2018)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)
Madhur K. Garg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation
Antoine Schernberg et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Epidemiology of Anal Canal Cancer
Valerie M. Nelson et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
Panagiotis Balermpas et al.
ONCOIMMUNOLOGY (2017)
Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?
D. Martin et al.
CLINICAL ONCOLOGY (2017)
HIV positivity and anal cancer outcomes: A single-center experience
Nicole Wieghard et al.
AMERICAN JOURNAL OF SURGERY (2016)
Immunohistochemistry and Polymerase Chain Reaction for Detection Human Papilloma Virus in Warts: A Comparative Study
Hong Sun Lee et al.
ANNALS OF DERMATOLOGY (2016)
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era
David Grew et al.
DISEASES OF THE COLON & RECTUM (2015)
Anal squamous cell carcinoma: An evolution in disease and management
Marc C. Osborne et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Prognostic Factors for Recurrence and Survival in Anal Cancer Generating Hypotheses From the Mature Outcomes of the First United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I)
Robert Glynne-Jones et al.
CANCER (2013)
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial
Roger D. James et al.
LANCET ONCOLOGY (2013)
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
Didier Peiffert et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
Dorothy A. Machalek et al.
LANCET ONCOLOGY (2012)
Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer
Peter P. Grimminger et al.
CLINICAL CANCER RESEARCH (2011)
Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: Are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?
Ingeborg Fraunholz et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Prognostic Factors Derived from A Prospective Database Dictate Clinical Biology of Anal Cancer The Intergroup Trial (RTOG 98-11)
Jaffer A. Ajani et al.
CANCER (2010)
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)